Global Coronavirus Disease 2019 (COVID-19) Clinical Trials globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
(PIXABAY / MANILA BULLETIN)
This after several social media posts claimed that CytoDyn’s Leronlimab is being sold for hundreds of thousands to millions of pesos.
The company said the initial 400 vials made available are being distributed for free for use in various hospitals in the country by critically ill COVID-19 patients under a CSP.
The Food and Drug Administration (FDA) has granted a CSP to only two physicians for the use of Leronlimab to treat COVID-19 patients.
Leronlimab is a humanized monoclonal antibody originally designed to treat human immunodeficiency virus (HIV) and cancer.
The immunomodulatory agent is now being used on critically ill patients due to its ability to mitigate the cytokine storm, common in COVID-19 fatalities, the company added.